Results 241 to 250 of about 86,485 (257)
Some of the next articles are maybe not open access.

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

European Journal of Internal Medicine, 2020
Corrado Campochiaro   +2 more
exaly  

Tocilizumab for severe COVID-19: a systematic review and meta-analysis

International Journal of Antimicrobial Agents, 2020
Li-Chin Lu   +2 more
exaly  

Successful treatment of IgG4-related disease with tocilizumab monotherapy

Autoimmunity Reviews, 2023
Mitsuhiro Akiyama   +2 more
exaly  

Evaluation of tocilizumab for intractable Takayasu arteritis and 18F-fluorodeoxyglucose-positron emission tomography for detecting inflammation under tocilizumab treatment

Journal of Cardiology, 2021
Yasuhiro Maejima, Mike Saji
exaly  

Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review

Multiple Sclerosis and Related Disorders, 2021
William Hoffman   +2 more
exaly  

Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review

Seminars in Arthritis and Rheumatism, 2020
Mitsuhiro Akiyama   +2 more
exaly  

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

Acta Ophthalmologica, 2016
Sukhum Silpa-Archa
exaly  

Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients

Journal of Autoimmunity, 2018
Carlo Salvarani   +2 more
exaly  

Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease

International Immunopharmacology, 2020
Shahnam Sedigh Maroufi   +2 more
exaly  

Tocilizumab in MOG-antibody spectrum disorder: a case report

Multiple Sclerosis and Related Disorders, 2019
Antonio Uccelli   +2 more
exaly  
covid-19
medicine
cytokine storm
cytokine release syndrome
mortality
critical care
interleukin-6
previous   23  24  25  26  

Home - About - Disclaimer - Privacy